ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMC.GB Crism Therapeutics Corp

10.00
0.00 (0.00%)
22 Nov 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Crism Therapeutics Corp AQSE:AMC.GB Aquis Stock Exchange Ordinary Share VGG042401262
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 8.00 12.00 10.00 10.00 10.00 0.00 06:53:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amur Minerals Corporation Cash shell update (3732J)

15/08/2023 9:30am

UK Regulatory


Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart


From Nov 2022 to Nov 2024

Click Here for more Crism Therapeutics Charts.

TIDMAMC

RNS Number : 3732J

Amur Minerals Corporation

15 August 2023

15 August 2023

Amur Minerals Corporation

("Amur" or the "Company")

Cash shell update

Further to the announcement of 6 March 2023 and the disposal of the Company's AO Kun-Manie subsidiary, following which Amur became an AIM Rule 15 cash shell, the board of Amur notes that the Company is required to make an acquisition or acquisitions which constitute(s) a reverse takeover under AIM Rule 14 on or before the date falling six months from the completion of the AO Kun-Manie disposal.

Accordingly, if no such transaction is completed, the Company will be suspended from trading on AIM at 7.30 a.m. on 7 September 2023. Once suspended, Amur will have a further six months to complete a reverse takeover or else admission of the Company's shares on AIM will be cancelled on 8 March 2024.

The board of Amur continues to review a number of reverse takeover opportunities. Further announcements will be made as appropriate.

Enquiries:

 
       Company            Nomad and Broker        Public Relations 
  Amur Minerals Corp.    S.P. Angel Corporate         BlytheRay 
                             Finance LLP 
   Robin Young CEO        Richard Morrison           Megan Ray 
                              Adam Cowl              Tim Blythe 
                           +44 (0) 20 3470 
 +44 (0) 7981 126 818            0470           +44 (0) 20 7138 3203 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCVELBFXVLLBBV

(END) Dow Jones Newswires

August 15, 2023 04:30 ET (08:30 GMT)

1 Year Crism Therapeutics Chart

1 Year Crism Therapeutics Chart

1 Month Crism Therapeutics Chart

1 Month Crism Therapeutics Chart

Your Recent History

Delayed Upgrade Clock